← Leaderboards
Frederick Ferris
National Eye Institute
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Eye Institute
Same institution · by research overlap
Others in their field
Top investigators on “Retina”
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Krzysztof Palczewski · University Of California-Irvine$48,214,939
- Adam R Glassman · Jaeb Center For Health Research, Inc.$47,242,041
- Cecilia Sungmin Lee · University Of Washington$32,086,169
- Adam Glassman · Jaeb Center For Health Research, Inc.$31,583,813
- Karen J Cruickshanks · University Of Wisconsin Madison$28,499,261
Research focus
RetinaParticipantCaringRetinalDiabeticMacular EdemaProtocols DocumentationFamilyGenotypeMedicalRecording Of Previous EventsRecruitment ActivityGeneticPharmaceutical PreparationsGenesBlood SpecimenOphthalmic Examination And EvaluationAffectSafetySecondary OutcomeUnited StatesPrimary OutcomeInflammationBlindness
Grant awards (22)
Eval. of Minocycline as a Microglia Inhibitor in Tx of Diabetic Macular Edema$63,038
ZIA · FY2014 · EY · contact PI
Genotype - phenotype Study of Patients with Plaquenil-induced Retinal Toxicity,$48,491
ZIA · FY2014 · EY · contact PI
SNPs in Patients with and without Diabetic Macular Edema$96,921
ZIA · FY2013 · EY · contact PI
Eval. of Minocycline as a Microglia Inhibitor in Tx of Diabetic Macular Edema$73,281
ZIA · FY2013 · EY · contact PI
Genotype - phenotype Study of Patients with Plaquenil^-induced Retinal Toxicity,$56,734
ZIA · FY2013 · EY · contact PI
Internal Monitoring of Eye Movement in Schizophrenia$23,639
ZIA · FY2013 · EY · contact PI
SNPs in Patients with and without Diabetic Macular Edema$99,838
ZIA · FY2012 · EY · contact PI
Eval. of Minocycline as a Microglia Inhibitor in Tx of Diabetic Macular Edema$87,663
ZIA · FY2012 · EY · contact PI
Genotype - phenotype Study of Patients with Plaquenil^-induced Retinal Toxicity,$82,793
ZIA · FY2012 · EY · contact PI
Internal Monitoring of Eye Movement in Schizophrenia$24,351
ZIA · FY2012 · EY · contact PI
Genotype - phenotype Study of Patients with Plaquenil^-induced Retinal Toxicity,$285,170
ZIA · FY2011 · EY · contact PI
Eval. of Minocycline as a Microglia Inhibitor in Tx of Diabetic Macular Edema$163,891
ZIA · FY2011 · EY · contact PI
Eval. of Subconjunctival Sirolimus in Treatment of Bilateral Geographic Atrophy$114,724
ZIA · FY2011 · EY · contact PI
Internal Monitoring of Eye Movement in Schizophrenia$32,778
ZIA · FY2011 · EY · contact PI
SNPs in Patients with and without Diabetic Macular Edema$3,278
ZIA · FY2011 · EY · contact PI
Genotype - phenotype Study of Patients with Plaquenil^-induced Retinal Toxicity,$312,164
ZIA · FY2010 · EY · contact PI
Eval. of Minocycline as a Microglia Inhibitor in Tx of Diabetic Macular Edema$190,420
ZIA · FY2010 · EY · contact PI
Pilot Validation Study of Computer Admin. of Vision Targeted Qual. of Life Instr$124,865
ZIA · FY2010 · EY · contact PI
Eval. of Subconjunctival Sirolimus in Treatment of Bilateral Geographic Atrophy$124,865
ZIA · FY2010 · EY · contact PI
Internal Monitoring of Eye Movement in Schizophrenia$31,216
ZIA · FY2010 · EY · contact PI
Evaluation of Sirolimus in the Treatment of Diabetic Macular Edema$9,365
ZIA · FY2010 · EY · contact PI
SNPs in Patients with and without Diabetic Macular Edema$9,365
ZIA · FY2010 · EY · contact PI